Aurinia Pharmaceuticals Inc. SEC filings AUPH
Aurinia Pharmaceuticals Inc. has 615 filings in SEC EDGAR's recent list, going back to Feb 28, 2014. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 16, 2025 | — |
| S-8 | Employee stock plan registration | May 26, 2023 | — |
| S-3ASR | Automatic shelf registration | Nov 19, 2021 | — |
| S-8 | Employee stock plan registration | Jun 25, 2021 | — |
| S-8 | Employee stock plan registration | Feb 24, 2021 | — |
| F-10/A | Amendment no. 1 to form f-10 | Jun 17, 2020 | — |
| S-8 | Employee stock plan registration | Jun 9, 2020 | — |
| F-X | Filing | May 29, 2020 | — |
| F-10 | Form f-10 | May 29, 2020 | — |
| S-8 | Employee stock plan registration | Sep 13, 2019 | — |
| S-8 | Employee stock plan registration | Jun 8, 2018 | — |
| F-10/A | Amendment no. 1 to form f-10 | Mar 26, 2018 | — |
| F-X | Filing | Jan 4, 2018 | — |
| F-10 | Form f-10 | Jan 4, 2018 | — |
| FWP | Free writing prospectus | Mar 14, 2017 | — |
| S-8 | Employee stock plan registration | Mar 3, 2017 | — |
| F-10/A | Amendment no. 1 to form f-10 | Oct 16, 2015 | — |
| F-X | Filing | Sep 17, 2015 | — |
| F-10 | Registration statement on form f-10 | Sep 17, 2015 | — |
| F-X | Form f-x | Apr 16, 2014 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AUPH (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Edmonton, Alberta, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1600620
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.